,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,1.77370279850351e-10,1.45798370036988e-07
2,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,1.28456541176826e-08,5.27956384236753e-06
3,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,2.0102146303549e-07,5.50798808717243e-05
4,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,4.36496187559757e-06,0.000896999665435301
5,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,6.95286622559813e-06,0.00112810996229268
6,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,8.23437928680789e-06,0.00112810996229268
7,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,5.54724257542558e-05,0.00651404770999976
8,WP_MEVALONATE_PATHWAY,7,Down,7.31658034029985e-05,0.0075177862996581
9,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.000121594677290351,0.0111056471925187
10,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Down,0.00023929792079632,0.0196702890894575
11,WP_COMPLEMENT_ACTIVATION,12,Up,0.00060982097925423,0.0455702586315434
12,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Down,0.000833271150979298,0.0570790738420819
13,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Down,0.00100170785586229,0.0633387582706771
14,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.00154279695893279,0.0878647956112658
15,WP_CREATINE_PATHWAY,2,Up,0.00160337218268733,0.0878647956112658
16,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.00254213258318516,0.127886311932812
17,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.00266687214334761,0.127886311932812
18,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.00280043018830976,0.127886311932812
19,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.00300726150105827,0.129789372425396
20,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.00330288828682903,0.129789372425396
21,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,15,Down,0.00331578688678018,0.129789372425396
22,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.00364748062913749,0.130357785963088
23,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.00364748062913749,0.130357785963088
24,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.00414456105537908,0.140097265962299
25,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.0044469946540735,0.140097265962299
26,WP_ACUTE_VIRAL_MYOCARDITIS,65,Down,0.00459226480992778,0.140097265962299
27,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Down,0.00460503742332728,0.140097265962299
28,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.00477216964348462,0.140097265962299
29,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.00506796457176267,0.143650581999618
30,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.00571198615604435,0.156508420675615
31,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.00657226825503561,0.174271113085138
32,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.00692302308820563,0.174291489784317
33,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.00699710360447987,0.174291489784317
34,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Down,0.00751217124028779,0.178685298538263
35,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.00760825480394063,0.178685298538263
36,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.00836401275921152,0.19097829133533
37,WP_DOPAMINE_METABOLISM,7,Down,0.00885465608106879,0.196716954017258
38,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.00929947476694338,0.201162322590196
39,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.00976000478960654,0.205710870180938
40,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.0112132910310616,0.230433130688315
41,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.0127361110474474,0.251560610416957
42,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.0128534618461219,0.251560610416957
43,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.0138210770128321,0.253018014460576
44,WP_TP53_NETWORK,16,Up,0.0144700546669585,0.253018014460576
45,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Down,0.0145870045189761,0.253018014460576
46,WP_AMINO_ACID_METABOLISM,59,Down,0.0146731069957444,0.253018014460576
47,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.0147747745670409,0.253018014460576
48,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.0147747745670409,0.253018014460576
49,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,70,Down,0.0155326317410238,0.260567822267786
50,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.0164317619695526,0.270138166779444
51,WP_PEPTIDE_GPCRS,15,Down,0.0176842594737532,0.285028652694611
52,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,90,Down,0.0185889897129887,0.288434428500748
53,WP_PROSTAGLANDIN_SIGNALING,22,Down,0.0188765049960402,0.288434428500748
54,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Down,0.0189482471277863,0.288434428500748
55,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.0201969685187531,0.293805576404288
56,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.0202120844887894,0.293805576404288
57,WP_IL19_SIGNALING,20,Down,0.0204256805651889,0.293805576404288
58,WP_FOCAL_ADHESION,119,Down,0.0207308070942198,0.293805576404288
59,WP_CHOLESTEROL_METABOLISM,53,Down,0.0212516534207948,0.2960823578287
60,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.0232564410287865,0.318613242094375
61,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.0255003743840687,0.343627995798433
62,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Down,0.02612106485896,0.346314763130083
63,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.0274247888104831,0.357828196860589
64,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Down,0.0286196380151204,0.367583475756703
65,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.0308782441330431,0.389423353424895
66,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.0322856503901173,0.389423353424895
67,WP_FERROPTOSIS,50,Down,0.0325814897701891,0.389423353424895
68,WP_RAC1PAK1P38MMP2_PATHWAY,51,Down,0.0329896864406408,0.389423353424895
69,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.0334177373982333,0.389423353424895
70,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.033559704250544,0.389423353424895
71,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.0340542250554078,0.389423353424895
72,WP_HEART_DEVELOPMENT,16,Down,0.0342753568271206,0.389423353424895
73,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Up,0.0345838257907754,0.389423353424895
74,WP_PROTEASOME_DEGRADATION,57,Down,0.037290270418073,0.400866633051792
75,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Down,0.0374899586966204,0.400866633051792
76,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.0375561874746349,0.400866633051792
77,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Up,0.0378953006053972,0.400866633051792
78,WP_NRF2_PATHWAY,72,Down,0.0383760683927317,0.400866633051792
79,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.0389306256009845,0.400866633051792
80,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.0390137842386173,0.400866633051792
81,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.0411177495060307,0.40798714675532
82,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Down,0.0414990288504749,0.40798714675532
83,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.0425728617975882,0.40798714675532
84,WP_RETINOL_METABOLISM,6,Down,0.0429766478955815,0.40798714675532
85,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.0437073190558408,0.40798714675532
86,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.0437073190558408,0.40798714675532
87,WP_MALE_INFERTILITY,68,Up,0.0437239067474737,0.40798714675532
88,WP_GASTRIN_SIGNALING,92,Down,0.0451001693280173,0.40798714675532
89,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.0453514580517842,0.40798714675532
90,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.0459422187456441,0.40798714675532
91,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,40,Down,0.0463141135527321,0.40798714675532
92,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.0469972846841884,0.40798714675532
93,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.0471572032746911,0.40798714675532
94,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.0474484723761738,0.40798714675532
95,WP_ALZHEIMERS_DISEASE,184,Down,0.0476511461166963,0.40798714675532
96,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Down,0.0476511461166963,0.40798714675532
97,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.0484100059175114,0.40798714675532
98,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Down,0.0486408033844542,0.40798714675532
99,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.0492246222316396,0.408713530044522
100,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.0511889150626419,0.416251097894471
101,WP_VEGFAVEGFR2_SIGNALING,340,Down,0.0512804513918366,0.416251097894471
102,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.0516515960890949,0.416251097894471
103,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.0546959124541252,0.431009959391991
104,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,52,Down,0.0548572791045093,0.431009959391991
105,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.0554387650545161,0.431009959391991
106,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.0555803597269477,0.431009959391991
107,WP_MACROPHAGE_MARKERS,8,Up,0.0571633951532564,0.439143091738101
108,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.0579621299458444,0.441156211254483
109,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.0587207502601381,0.442829878108564
110,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.0617161900240672,0.458679836562562
111,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Down,0.0619385180759664,0.458679836562562
112,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.0628367441353846,0.459309413794258
113,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.0637025227837396,0.459309413794258
114,WP_HYPERTROPHY_MODEL,12,Down,0.0638229876011511,0.459309413794258
115,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.0644007704063489,0.459309413794258
116,WP_ENDOTHELIN_PATHWAYS,12,Down,0.0651288049143293,0.459309413794258
117,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.0662281193772293,0.459309413794258
118,WP_HISTONE_MODIFICATIONS,37,Up,0.0665089421961133,0.459309413794258
119,WP_NOTCH_SIGNALING_WP268,35,Down,0.0671357037757017,0.459309413794258
120,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Down,0.0674293415493435,0.459309413794258
121,WP_GLUTATHIONE_METABOLISM,10,Down,0.0676112397434371,0.459309413794258
122,WP_OSTEOBLAST_SIGNALING,3,Down,0.0703197488435601,0.473793717618086
123,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.0721882994811481,0.47864181194179
124,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.0722038743075206,0.47864181194179
125,WP_SMALL_LIGAND_GPCRS,7,Down,0.0738129743352854,0.485394119228837
126,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.0750788492288872,0.489800111636074
127,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,88,Down,0.0771754621481251,0.499513621147707
128,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.0783872177584769,0.499655083143489
129,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.0791027247970904,0.499655083143489
130,WP_CCL18_SIGNALING,20,Down,0.0798115023974757,0.499655083143489
131,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.0798352098180317,0.499655083143489
132,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Down,0.0802365826945749,0.499655083143489
133,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Up,0.0838273066452373,0.518090571897632
134,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Up,0.0846325763469416,0.519164013113328
135,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.0861550287104062,0.524265130346921
136,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.0870749182349516,0.524265130346921
137,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.0873775217244868,0.524265130346921
138,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,61,Down,0.0901949425278819,0.53300081164222
139,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.0904867616009355,0.53300081164222
140,WP_PRION_DISEASE_PATHWAY,28,Down,0.0907787270436871,0.53300081164222
141,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.0934631213604891,0.544870111761149
142,WP_G_PROTEIN_SIGNALING,62,Down,0.0952862032718955,0.551586331616184
143,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.0973759246073213,0.555902922330778
144,WP_METHYLATION_PATHWAYS,5,Down,0.0975798309490988,0.555902922330778
145,WP_KININKALLIKREIN_PATHWAY,2,Down,0.0984141119262862,0.555902922330778
146,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Down,0.098737015401817,0.555902922330778
147,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.0996542095017821,0.557042068154963
148,WP_G13_SIGNALING,29,Down,0.100294678937877,0.557042068154963
149,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.103406076553418,0.569778458156656
150,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Up,0.10397417119647,0.569778458156656
151,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.105042135968558,0.571162138126534
152,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Down,0.10561635644189,0.571162138126534
153,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,40,Down,0.108721634096773,0.580183589858415
154,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Down,0.109805834203505,0.580183589858415
155,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.110417010604912,0.580183589858415
156,WP_ATM_SIGNALING,34,Up,0.110834877469513,0.580183589858415
157,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.111027907936038,0.580183589858415
158,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.111519473476435,0.580183589858415
159,WP_NOTCH_SIGNALING_WP61,49,Down,0.115056312877961,0.593871686592182
160,WP_KLEEFSTRA_SYNDROME,25,Up,0.115772379831113,0.593871686592182
161,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.11631793374859,0.593871686592182
162,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.117158060875609,0.594468679257719
163,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.118074095142284,0.595441142373973
164,WP_CHEMOKINE_SIGNALING,110,Down,0.120054785951362,0.601738012512313
165,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Down,0.12302610582825,0.612893690853465
166,WP_AXON_GUIDANCE,38,Down,0.125080555160799,0.614403662377938
167,WP_IL26_SIGNALING,31,Down,0.126694391835099,0.614403662377938
168,WP_IL3_SIGNALING,46,Down,0.128001774880322,0.614403662377938
169,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.12829068673745,0.614403662377938
170,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.128820072440578,0.614403662377938
171,WP_DNA_MISMATCH_REPAIR,21,Up,0.129311990940971,0.614403662377938
172,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.129525020712251,0.614403662377938
173,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.129814336027746,0.614403662377938
174,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.131232844165582,0.614403662377938
175,WP_NEPHROTIC_SYNDROME,27,Down,0.132008907495814,0.614403662377938
176,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.132408418199152,0.614403662377938
177,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.132499465134242,0.614403662377938
178,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.133046048544128,0.614403662377938
179,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.136202515013187,0.6184068250194
180,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.13625570529186,0.6184068250194
181,WP_GLIOBLASTOMA_SIGNALING,68,Up,0.136344423492703,0.6184068250194
182,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.137008688174991,0.6184068250194
183,WP_DNA_DAMAGE_RESPONSE,59,Up,0.139632052457263,0.6184068250194
184,WP_AEROBIC_GLYCOLYSIS,10,Down,0.139890022521762,0.6184068250194
185,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.139890022521762,0.6184068250194
186,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.141334788720476,0.6184068250194
187,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.142411248125851,0.6184068250194
188,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.142581259636296,0.6184068250194
189,WP_ECTODERM_DIFFERENTIATION,78,Down,0.144047822677906,0.6184068250194
190,WP_NUCLEAR_RECEPTORS_METAPATHWAY,177,Down,0.144300489282896,0.6184068250194
191,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.14441516942177,0.6184068250194
192,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.145153698395332,0.6184068250194
193,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.145804131274199,0.6184068250194
194,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.145950029262486,0.6184068250194
195,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.146781149578344,0.618738999761018
196,WP_SPHINGOLIPID_PATHWAY,20,Down,0.148157689243684,0.619687135634333
197,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.149385707487295,0.619687135634333
198,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.149944725856056,0.619687135634333
199,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.150603350563004,0.619687135634333
200,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.151113717863526,0.619687135634333
201,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.151549948499141,0.619687135634333
202,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.152715813980508,0.619687135634333
203,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.153187003933514,0.619687135634333
204,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Down,0.154722770664967,0.619687135634333
205,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.155522079114155,0.619687135634333
206,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,49,Down,0.155571807908651,0.619687135634333
207,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.156052599849522,0.619687135634333
208,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Down,0.156861546391023,0.619904765064524
209,WP_IL7_SIGNALING,23,Down,0.157708342121264,0.620269173319037
210,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.161551354054142,0.625987010541938
211,WP_CAMKK2_PATHWAY,29,Down,0.165769054110346,0.625987010541938
212,WP_GLUCURONIDATION,7,Down,0.166321925771665,0.625987010541938
213,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.166912234184435,0.625987010541938
214,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.166954986985238,0.625987010541938
215,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.166989076555279,0.625987010541938
216,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.167306411080832,0.625987010541938
217,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Down,0.167326031039965,0.625987010541938
218,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.167525398463601,0.625987010541938
219,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.167616065579394,0.625987010541938
220,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Down,0.167744161950149,0.625987010541938
221,WP_PURINERGIC_SIGNALING,15,Down,0.168726703788307,0.625987010541938
222,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.169184804902639,0.625987010541938
223,WP_MONOAMINE_TRANSPORT,11,Up,0.1698237267042,0.625987010541938
224,WP_ERBB_SIGNALING,68,Up,0.171014303639361,0.62756141781944
225,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Down,0.175497238952393,0.636963738835544
226,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.175627921590872,0.636963738835544
227,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.175901178486215,0.636963738835544
228,WP_NPHP1_DELETION_SYNDROME,10,Down,0.18046625807108,0.648438828703952
229,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.180731418776403,0.648438828703952
230,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Down,0.182924941646142,0.648438828703952
231,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.183228365473289,0.648438828703952
232,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,28,Down,0.183798896680661,0.648438828703952
233,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.185018535475328,0.648438828703952
234,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Down,0.185089676001681,0.648438828703952
235,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.185380930347237,0.648438828703952
236,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Down,0.186777780366709,0.649608086490941
237,WP_PDGF_PATHWAY,36,Down,0.187295762163446,0.649608086490941
238,WP_ZINC_HOMEOSTASIS,21,Down,0.188675248805776,0.65072712874267
239,WP_GPCRS_CLASS_A_RHODOPSINLIKE,43,Down,0.189201683417881,0.65072712874267
240,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.190913813495514,0.653879811222136
241,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.193626621361408,0.658305297621909
242,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Down,0.193852374656418,0.658305297621909
243,WP_ATR_SIGNALING,10,Up,0.194641803558362,0.658305297621909
244,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.195639682046781,0.658305297621909
245,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,72,Up,0.196498451619238,0.658305297621909
246,WP_SERINE_METABOLISM,5,Up,0.197967863942706,0.658305297621909
247,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.198155684225101,0.658305297621909
248,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.198614586010213,0.658305297621909
249,WP_CORI_CYCLE,11,Down,0.200116575340415,0.658305297621909
250,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.200214506576006,0.658305297621909
251,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,126,Down,0.202199635841674,0.662183667975523
252,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.207087268769057,0.675498948127639
253,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.207919337288345,0.675532392296522
254,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.211725466634827,0.67642783930404
255,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.212213090327267,0.67642783930404
256,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Down,0.212670644977857,0.67642783930404
257,WP_16P112_DISTAL_DELETION_SYNDROME,20,Up,0.212694661686288,0.67642783930404
258,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Down,0.213146450027318,0.67642783930404
259,WP_CANCER_PATHWAYS,306,Down,0.214560463210761,0.67642783930404
260,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.215568359594295,0.67642783930404
261,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,271,Down,0.215578812179076,0.67642783930404
262,WP_FATTY_ACID_BETAOXIDATION,29,Down,0.215676743452419,0.67642783930404
263,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.216423992380733,0.67642783930404
264,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Up,0.217300879976194,0.676595921744059
265,WP_SELENIUM_MICRONUTRIENT_NETWORK,49,Down,0.2221418385709,0.682322780165777
266,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.224665810453248,0.682322780165777
267,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Down,0.22492082241182,0.682322780165777
268,WP_PDGFRBETA_PATHWAY,27,Down,0.225482375777803,0.682322780165777
269,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Up,0.226208300159466,0.682322780165777
270,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Down,0.227431355933993,0.682322780165777
271,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.227462659687396,0.682322780165777
272,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.228240885757734,0.682322780165777
273,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.228889801200203,0.682322780165777
274,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.229063844725597,0.682322780165777
275,WP_REGULATION_OF_ACTIN_CYTOSKELETON,93,Down,0.229836961765562,0.682322780165777
276,WP_COPPER_HOMEOSTASIS,39,Down,0.229838084629343,0.682322780165777
277,WP_RETINOBLASTOMA_GENE_IN_CANCER,72,Up,0.229931155846618,0.682322780165777
278,WP_AGERAGE_PATHWAY,54,Down,0.231584553287597,0.684757204325196
279,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.235375336864638,0.68935873713228
280,WP_SPINAL_CORD_INJURY,66,Down,0.235837768100731,0.68935873713228
281,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.237299298642725,0.68935873713228
282,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Down,0.237519884782545,0.68935873713228
283,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.238164949995647,0.68935873713228
284,WP_GASTRIC_CANCER_NETWORK_1,18,Up,0.238172605043269,0.68935873713228
285,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Down,0.239682555281176,0.691294948916234
286,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.242115637862088,0.69292016792196
287,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.242309314948668,0.69292016792196
288,WP_GASTRIC_CANCER_NETWORK_2,26,Up,0.24277494934492,0.69292016792196
289,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Up,0.245417426669993,0.695683714003747
290,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.246498874860866,0.695683714003747
291,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.246814391768588,0.695683714003747
292,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.24712852127627,0.695683714003747
293,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Down,0.249571006079673,0.700161662107477
294,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.250754660104417,0.701089559883778
295,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.255752252649206,0.71263848026321
296,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Up,0.258713505340567,0.718454396587656
297,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.259873712155399,0.719246435662418
298,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.263564170859558,0.724746611759706
299,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.263624375810404,0.724746611759706
300,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.26918991329298,0.737580362422765
301,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Down,0.270945884740589,0.739925306500878
302,WP_TAMOXIFEN_METABOLISM,2,Up,0.272679137578248,0.742192884401722
303,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.27489896785769,0.742698350084624
304,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Down,0.276459595949545,0.742698350084624
305,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.277550175537106,0.742698350084624
306,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.277628734220859,0.742698350084624
307,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.278155079303676,0.742698350084624
308,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.278285999788399,0.742698350084624
309,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.2806204948857,0.744096925148533
310,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.2806204948857,0.744096925148533
311,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,22,Down,0.281580569307507,0.744241890581256
312,WP_BENZENE_METABOLISM,3,Down,0.284711248213393,0.750104634716055
313,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.285907924383271,0.750850842949038
314,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.287292682250503,0.752084664999726
315,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Up,0.291951354007781,0.754859891623552
316,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.293057077034409,0.754859891623552
317,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.294732251572878,0.754859891623552
318,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.29511675783782,0.754859891623552
319,WP_MAPK_SIGNALING,161,Down,0.2953545955715,0.754859891623552
320,WP_KREBS_CYCLE_DISORDERS,11,Down,0.296463224591088,0.754859891623552
321,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Down,0.296547508821252,0.754859891623552
322,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.296628392375346,0.754859891623552
323,WP_VITAMIN_D_METABOLISM,6,Down,0.297014543757534,0.754859891623552
324,WP_LUNG_FIBROSIS,33,Down,0.298070521405383,0.754859891623552
325,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Down,0.298454336712475,0.754859891623552
326,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.301888974003132,0.76024262086901
327,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.302912103636926,0.76024262086901
328,WP_HIPPOYAP_SIGNALING,16,Down,0.303644147250483,0.76024262086901
329,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Up,0.304282022221295,0.76024262086901
330,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.308786631163909,0.769159426717374
331,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Down,0.310869283011194,0.772007705846529
332,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.312141440303159,0.772044625445014
333,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.312762603738673,0.772044625445014
334,WP_7OXOC_AND_7BETAHC_PATHWAYS,18,Down,0.316338514428664,0.77465064643497
335,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.316446559768705,0.77465064643497
336,WP_RAS_SIGNALING,116,Down,0.319450610134003,0.77465064643497
337,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Down,0.31960960136369,0.77465064643497
338,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,136,Down,0.319673213612086,0.77465064643497
339,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.31985536482169,0.77465064643497
340,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.322460860090147,0.77465064643497
341,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Up,0.323451870662268,0.77465064643497
342,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.32412525906772,0.77465064643497
343,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.324897169791533,0.77465064643497
344,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.32577181987288,0.77465064643497
345,WP_INTEGRATED_CANCER_PATHWAY,41,Up,0.327037934087386,0.77465064643497
346,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.32784988285923,0.77465064643497
347,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.327926590293991,0.77465064643497
348,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.327954288271739,0.77465064643497
349,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.330216371783853,0.776334364922113
350,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Up,0.332162658764283,0.776334364922113
351,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.332362991926956,0.776334364922113
352,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Up,0.332444886195357,0.776334364922113
353,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.335612799285368,0.781511957542699
354,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.336775816902088,0.782004862976034
355,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.341753846608544,0.785497670420732
356,WP_TNFALPHA_SIGNALING,84,Down,0.342050838464316,0.785497670420732
357,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.343002544378958,0.785497670420732
358,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Up,0.343444873899619,0.785497670420732
359,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.344132491596224,0.785497670420732
360,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.344454785724668,0.785497670420732
361,WP_SULFATASE_AND_AROMATASE_PATHWAY,4,Up,0.346398057901489,0.785497670420732
362,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.346666420574098,0.785497670420732
363,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.348284828959267,0.785497670420732
364,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.349166974725971,0.785497670420732
365,WP_MONOAMINE_GPCRS,3,Down,0.349721396934949,0.785497670420732
366,WP_NRF2ARE_REGULATION,20,Down,0.350603395639773,0.785497670420732
367,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.350702731197577,0.785497670420732
368,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Down,0.352693351880244,0.787809606645545
369,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.354178416478948,0.788982813944974
370,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.355402488362621,0.789569852524526
371,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Down,0.360967063241911,0.799770689986122
372,WP_SILDENAFIL_TREATMENT,11,Up,0.364222898903855,0.800563460203019
373,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.36451653305619,0.800563460203019
374,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Up,0.364713541515585,0.800563460203019
375,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.365220556661961,0.800563460203019
376,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.369170415436571,0.800813229367626
377,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.369750750655131,0.800813229367626
378,WP_ID_SIGNALING,12,Up,0.369860203979331,0.800813229367626
379,WP_CYTOSINE_METHYLATION,7,Down,0.370734301060519,0.800813229367626
380,WP_TYPE_II_DIABETES_MELLITUS,14,Up,0.371092210308842,0.800813229367626
381,WP_GLYOXYLATE_METABOLISM,5,Down,0.371179854487914,0.800813229367626
382,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Up,0.374109847372387,0.805021713455765
383,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Up,0.376215418951451,0.805587927646854
384,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,32,Down,0.378405607479666,0.805587927646854
385,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.379185327627438,0.805587927646854
386,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.379694260703054,0.805587927646854
387,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.380437765088766,0.805587927646854
388,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.380764428040729,0.805587927646854
389,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Up,0.381233216368159,0.805587927646854
390,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,80,Down,0.382683133329186,0.806578296401515
391,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.38467075118018,0.807301427939406
392,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.384990461985702,0.807301427939406
393,WP_SLEEP_REGULATION,11,Up,0.388370190147511,0.811368040363095
394,WP_HIPPO_SIGNALING_REGULATION,44,Down,0.389237089049932,0.811368040363095
395,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.389890968301,0.811368040363095
396,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.392035314442073,0.81248670722742
397,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.392405380497915,0.81248670722742
398,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.399895151453649,0.822461049511409
399,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Up,0.400222784071954,0.822461049511409
400,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.400224354993386,0.822461049511409
401,WP_VITAMIN_B12_DISORDERS,9,Down,0.404543042591785,0.829262795537274
402,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.407293379812011,0.8304515963061
403,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.407348193631855,0.8304515963061
404,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Down,0.410489675106281,0.8304515963061
405,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,37,Down,0.410957339783096,0.8304515963061
406,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.41168798123443,0.8304515963061
407,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Up,0.411934205624013,0.8304515963061
408,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.412194952911057,0.8304515963061
409,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,166,Down,0.414032622826187,0.832016246397477
410,WP_ALPHA_6_BETA_4_SIGNALING,26,Up,0.416653975445199,0.832016246397477
411,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.417964466118938,0.832016246397477
412,WP_KIT_RECEPTOR_SIGNALING,51,Up,0.418023456783255,0.832016246397477
413,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.418032493627929,0.832016246397477
414,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.420362953609884,0.834579910282927
415,WP_MEASLES_VIRUS_INFECTION,100,Down,0.421351171249896,0.834579910282927
416,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.425324403165143,0.839486503172913
417,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.426322408934348,0.839486503172913
418,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Up,0.426892163413963,0.839486503172913
419,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.428846461923989,0.841316925301955
420,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.43156316883122,0.843339726181879
421,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Up,0.432763924135784,0.843339726181879
422,WP_SPINA_BIFIDA,10,Up,0.432955431202862,0.843339726181879
423,WP_15Q11Q13_COPY_NUMBER_VARIATION,35,Up,0.440023981948657,0.855082064212284
424,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,15,Down,0.441399229383077,0.85573152488889
425,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,57,Up,0.44734905697822,0.855907946069313
426,WP_FOXP3_IN_COVID19,9,Down,0.447372524691827,0.855907946069313
427,WP_NONSMALL_CELL_LUNG_CANCER,60,Up,0.448494474328528,0.855907946069313
428,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.4488501610481,0.855907946069313
429,WP_SEROTONIN_TRANSPORTER_ACTIVITY,3,Down,0.449587166464096,0.855907946069313
430,WP_MELANOMA,55,Up,0.449636251958181,0.855907946069313
431,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.451560982095844,0.855907946069313
432,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.45408119484538,0.855907946069313
433,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.454530920707133,0.855907946069313
434,WP_IL1_SIGNALING,52,Down,0.454562692404947,0.855907946069313
435,WP_NUCLEAR_RECEPTORS,20,Up,0.454593175109888,0.855907946069313
436,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.454894946296704,0.855907946069313
437,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.457799220453026,0.855907946069313
438,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.457848244007555,0.855907946069313
439,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.459485448934655,0.855907946069313
440,WP_ASPIRIN_AND_MIRNAS,8,Down,0.459726495779694,0.855907946069313
441,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.461625596976427,0.855907946069313
442,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,74,Down,0.46169618494377,0.855907946069313
443,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.462288977755968,0.855907946069313
444,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.462315240942549,0.855907946069313
445,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Down,0.46455167658279,0.858115681238323
446,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.466390326003093,0.85832329245201
447,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Up,0.467865319849,0.85832329245201
448,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.469967528360907,0.85832329245201
449,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Up,0.471547013802869,0.85832329245201
450,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.472001327932288,0.85832329245201
451,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.472441325977359,0.85832329245201
452,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.473104271151738,0.85832329245201
453,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.474833180236373,0.85832329245201
454,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Up,0.476622039697236,0.85832329245201
455,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Up,0.476981021382986,0.85832329245201
456,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.47728983241222,0.85832329245201
457,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Up,0.477910333375909,0.85832329245201
458,WP_KETOGENESIS_AND_KETOLYSIS,6,Down,0.478989117163493,0.85832329245201
459,WP_HEPATITIS_B_INFECTION,116,Down,0.479288138146794,0.85832329245201
460,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.480718626205346,0.85832329245201
461,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Down,0.482627950016188,0.85832329245201
462,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Up,0.484212001946843,0.85832329245201
463,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.48763019644415,0.85832329245201
464,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.48820239261558,0.85832329245201
465,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.488379716266993,0.85832329245201
466,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Up,0.489919764807387,0.85832329245201
467,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.490075065515809,0.85832329245201
468,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.490115503882501,0.85832329245201
469,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.49074215070377,0.85832329245201
470,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Down,0.491040893882734,0.85832329245201
471,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.49181298144148,0.85832329245201
472,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.493091385370493,0.858731183844375
473,WP_IRON_METABOLISM_DISORDERS,10,Down,0.497341024280364,0.861782221623539
474,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.498154983145263,0.861782221623539
475,WP_TGFB_SMAD_SIGNALING,7,Down,0.499396314423175,0.861782221623539
476,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.499449579851962,0.861782221623539
477,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.500085303788842,0.861782221623539
478,WP_STEROID_BIOSYNTHESIS,3,Up,0.504490989181325,0.867555634115166
479,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.50667489843096,0.868732448386213
480,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.507384575697441,0.868732448386213
481,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.508345873082443,0.868732448386213
482,WP_TAR_SYNDROME,43,Down,0.509949058882281,0.869664162658164
483,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Down,0.511076657502714,0.869782634507724
484,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.512437182163066,0.870296206070332
485,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.51424065482086,0.871077891042634
486,WP_BDNFTRKB_SIGNALING,26,Up,0.515016855287981,0.871077891042634
487,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.521453557229973,0.880153642798846
488,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.526329340884824,0.886562947146159
489,WP_BENZOAPYRENE_METABOLISM,5,Down,0.52751635089558,0.886745276965577
490,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.532093459165889,0.891431280464784
491,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.532472942467407,0.891431280464784
492,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.5360302651744,0.893723525876235
493,WP_MESODERMAL_COMMITMENT_PATHWAY,77,Up,0.538387780413102,0.893723525876235
494,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.540951317822831,0.893723525876235
495,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.540982372285956,0.893723525876235
496,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,15,Down,0.541419931429553,0.893723525876235
497,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.541520820935744,0.893723525876235
498,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Down,0.542169497367694,0.893723525876235
499,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.544101866554487,0.893723525876235
500,WP_NEURAL_CREST_DIFFERENTIATION,41,Down,0.544112706448283,0.893723525876235
501,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.545603297470005,0.893723525876235
502,WP_ENERGY_METABOLISM,41,Down,0.545801958625146,0.893723525876235
503,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.547717111762702,0.894051447777937
504,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.548177530024428,0.894051447777937
505,WP_JOUBERT_SYNDROME,71,Down,0.552327642294968,0.897696219818804
506,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.552596456482135,0.897696219818804
507,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.554555171350116,0.899101283727407
508,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.556354644966646,0.900243145989336
509,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.560413133762537,0.902150481849235
510,WP_WNT_SIGNALING_WP428,59,Down,0.563819759983729,0.902150481849235
511,WP_MATRIX_METALLOPROTEINASES,8,Down,0.564727747067503,0.902150481849235
512,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.564831330793399,0.902150481849235
513,WP_THERMOGENESIS,74,Down,0.565214035887733,0.902150481849235
514,WP_MTHFR_DEFICIENCY,18,Down,0.565253285027015,0.902150481849235
515,WP_INTERFERON_TYPE_I_SIGNALING,50,Up,0.565621518642768,0.902150481849235
516,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.566622365783367,0.902150481849235
517,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Up,0.567864872247154,0.902150481849235
518,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.568985088562516,0.902150481849235
519,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.569605961167583,0.902150481849235
520,WP_MAPK_CASCADE,30,Up,0.57207191808921,0.904313685902558
521,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.575773835386933,0.906375975417759
522,WP_BASE_EXCISION_REPAIR,29,Up,0.577368297694528,0.906375975417759
523,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.577742084113912,0.906375975417759
524,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.578218506151907,0.906375975417759
525,WP_MRNA_PROCESSING,124,Up,0.579315266854846,0.906375975417759
526,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.581053470929166,0.906375975417759
527,WP_IL5_SIGNALING,37,Down,0.581095059665644,0.906375975417759
528,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.583464678740572,0.907106708471409
529,WP_ARYLAMINE_METABOLISM,1,Down,0.586294758059075,0.907106708471409
530,WP_FOXA2_PATHWAY,9,Up,0.58687178324355,0.907106708471409
531,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.58701291142115,0.907106708471409
532,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.588716330728027,0.907106708471409
533,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.589387557601063,0.907106708471409
534,WP_RANKLRANK_SIGNALING,47,Up,0.589898247390995,0.907106708471409
535,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.591525367902051,0.907106708471409
536,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.591939135790492,0.907106708471409
537,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,34,Up,0.592598908088986,0.907106708471409
538,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.596976693180651,0.910748077909138
539,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.597241192576319,0.910748077909138
540,WP_CILIARY_LANDSCAPE,185,Down,0.598674393024627,0.910748077909138
541,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Up,0.601952656741757,0.910748077909138
542,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Up,0.603655166240642,0.910748077909138
543,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Down,0.606068673718206,0.910748077909138
544,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.606305514581214,0.910748077909138
545,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Up,0.607291892001713,0.910748077909138
546,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.608112791931239,0.910748077909138
547,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.608681843365172,0.910748077909138
548,WP_ESTROGEN_SIGNALING,21,Up,0.610880261919194,0.910748077909138
549,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Up,0.610974944322063,0.910748077909138
550,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.6113325840282,0.910748077909138
551,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.612094476426595,0.910748077909138
552,WP_ACUTE_MYELOID_LEUKEMIA,55,Down,0.612508910355938,0.910748077909138
553,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Up,0.612705215430357,0.910748077909138
554,WP_TRYPTOPHAN_METABOLISM,19,Down,0.614721474566363,0.912095761901716
555,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.617100283896736,0.91273600814374
556,WP_CHOLESTASIS,9,Down,0.618268056187014,0.91273600814374
557,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Up,0.62149483327825,0.91273600814374
558,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Up,0.622580006835311,0.91273600814374
559,WP_ADIPOGENESIS,86,Down,0.62276442016932,0.91273600814374
560,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.626451075135666,0.91273600814374
561,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.627232480041984,0.91273600814374
562,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.627961849184672,0.91273600814374
563,WP_TRANSLATION_FACTORS,49,Up,0.628328568820464,0.91273600814374
564,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.628982290519278,0.91273600814374
565,WP_VITAMIN_D_RECEPTOR_PATHWAY,83,Down,0.630979079768091,0.91273600814374
566,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.631872456100902,0.91273600814374
567,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.632637592966942,0.91273600814374
568,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,77,Down,0.633660043572306,0.91273600814374
569,WP_ONECARBON_METABOLISM,22,Up,0.63666535138435,0.91273600814374
570,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.637391183023021,0.91273600814374
571,WP_BARDETBIEDL_SYNDROME,65,Up,0.637425220545681,0.91273600814374
572,WP_CIRCADIAN_RHYTHM_GENES,121,Up,0.640152792546879,0.91273600814374
573,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.640463535883995,0.91273600814374
574,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.64058422165963,0.91273600814374
575,WP_PI3KAKT_SIGNALING,178,Down,0.642264247400185,0.91273600814374
576,WP_BURN_WOUND_HEALING,60,Up,0.642614844258026,0.91273600814374
577,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Down,0.643179714169711,0.91273600814374
578,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.645798504209198,0.91273600814374
579,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.647163728814619,0.91273600814374
580,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.647517139771022,0.91273600814374
581,WP_INSULIN_SIGNALING,130,Up,0.6484545464729,0.91273600814374
582,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.649477720335629,0.91273600814374
583,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.652638449315048,0.91273600814374
584,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,14,Down,0.653576349488311,0.91273600814374
585,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Up,0.654632333710635,0.91273600814374
586,WP_IRINOTECAN_PATHWAY,5,Up,0.655116989631703,0.91273600814374
587,WP_IL2_SIGNALING,37,Down,0.655281881140243,0.91273600814374
588,WP_IL6_SIGNALING,38,Down,0.655968229555159,0.91273600814374
589,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.65746413064041,0.91273600814374
590,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.659043496542918,0.91273600814374
591,WP_PYRIMIDINE_METABOLISM,71,Up,0.659538448887746,0.91273600814374
592,WP_VITAMIN_B12_METABOLISM,23,Up,0.659735231986893,0.91273600814374
593,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.66045667142305,0.91273600814374
594,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.660546127926119,0.91273600814374
595,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.660678740687987,0.91273600814374
596,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.663380604579915,0.914930968061561
597,WP_5Q35_COPY_NUMBER_VARIATION,76,Down,0.664596721612665,0.915072872974222
598,WP_OSTEOCLAST_SIGNALING,9,Down,0.667059858666377,0.915682460697868
599,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Down,0.667267389243337,0.915682460697868
600,WP_LEPTIN_SIGNALING,69,Down,0.66862239694781,0.9160126838185
601,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.670884206678509,0.916646648435082
602,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.671315428659269,0.916646648435082
603,WP_PPARALPHA_PATHWAY,15,Up,0.674121529555385,0.918951736806844
604,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.678835551989795,0.923845734661609
605,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.682055231228779,0.925188197683723
606,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.682073050847124,0.925188197683723
607,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.683645255121275,0.925793080246604
608,WP_BREAST_CANCER_PATHWAY,88,Up,0.68647249773739,0.927056467058231
609,WP_FOLATE_METABOLISM,36,Up,0.686833805886208,0.927056467058231
610,WP_OREXIN_RECEPTOR_PATHWAY,119,Up,0.690797572215194,0.927707605465611
611,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.69110066660954,0.927707605465611
612,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.691255978616486,0.927707605465611
613,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Down,0.691830610888588,0.927707605465611
614,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.694938533484649,0.929143922813718
615,WP_PURINE_METABOLISM,10,Up,0.695162424002964,0.929143922813718
616,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.696308498066405,0.92916491138082
617,WP_IL9_SIGNALING,15,Down,0.698623734152292,0.930743451334172
618,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,93,Down,0.700386569732667,0.931582136440537
619,WP_ALLOGRAFT_REJECTION,50,Up,0.706008846548852,0.937543250182805
620,WP_ACETYLCHOLINE_SYNTHESIS,4,Up,0.70955348181003,0.940730583948136
621,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.713829925395498,0.94487632636892
622,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.715907929244576,0.945236770639961
623,WP_CILIOPATHIES,127,Up,0.716850568970871,0.945236770639961
624,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.717552001069752,0.945236770639961
625,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.721020944781858,0.946159664166718
626,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.724414531551657,0.946159664166718
627,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.727147730984175,0.946159664166718
628,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.727677258193168,0.946159664166718
629,WP_APOPTOSIS,72,Up,0.729517819508753,0.946159664166718
630,WP_IL11_SIGNALING,40,Down,0.731964709506687,0.946159664166718
631,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.731975709215701,0.946159664166718
632,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.732257904389545,0.946159664166718
633,WP_IL4_SIGNALING,50,Down,0.732889671321301,0.946159664166718
634,WP_WNT_SIGNALING_WP363,38,Down,0.733510875782457,0.946159664166718
635,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.734330929176422,0.946159664166718
636,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,84,Down,0.736412866045163,0.946159664166718
637,WP_NETRINUNC5B_SIGNALING,35,Down,0.73657562576693,0.946159664166718
638,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.737213959331013,0.946159664166718
639,WP_PPAR_SIGNALING,39,Down,0.737296263469685,0.946159664166718
640,WP_SYNAPTIC_VESICLE_PATHWAY,22,Down,0.737810449592135,0.946159664166718
641,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,22,Down,0.74115248392759,0.946159664166718
642,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.7412061607434,0.946159664166718
643,WP_GALANIN_RECEPTOR_PATHWAY,10,Up,0.741936552630976,0.946159664166718
644,WP_KALLMANN_SYNDROME,11,Down,0.742624460756952,0.946159664166718
645,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.743174889996417,0.946159664166718
646,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.743852611984748,0.946159664166718
647,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.748063023990995,0.946159664166718
648,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Up,0.748162942554204,0.946159664166718
649,WP_CELLULAR_PROTEOSTASIS,6,Down,0.749317809386197,0.946159664166718
650,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.74990059561547,0.946159664166718
651,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,5,Up,0.751258947057223,0.946159664166718
652,WP_SMALL_CELL_LUNG_CANCER,70,Up,0.755382966239615,0.946159664166718
653,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,48,Down,0.756382146992997,0.946159664166718
654,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Up,0.757888040454869,0.946159664166718
655,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Down,0.760057688842659,0.946159664166718
656,WP_COMPLEMENT_SYSTEM,51,Down,0.760713528796872,0.946159664166718
657,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.761137088091842,0.946159664166718
658,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Up,0.761579148576304,0.946159664166718
659,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.762304174930689,0.946159664166718
660,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.762556769749787,0.946159664166718
661,WP_DRAVET_SYNDROME,14,Up,0.765183810135621,0.946159664166718
662,WP_RETT_SYNDROME,31,Up,0.765554025690903,0.946159664166718
663,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.765575322425754,0.946159664166718
664,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.76757373435065,0.946159664166718
665,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.772126256362326,0.946159664166718
666,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Down,0.77240500153235,0.946159664166718
667,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.772507407034229,0.946159664166718
668,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.772507407034229,0.946159664166718
669,WP_OSTEOPONTIN_SIGNALING,11,Up,0.772944414608066,0.946159664166718
670,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.773533053770765,0.946159664166718
671,WP_AUTOPHAGY,27,Up,0.77364728306158,0.946159664166718
672,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.77458239835102,0.946159664166718
673,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.774653836963748,0.946159664166718
674,WP_TCELL_RECEPTOR_SIGNALING,72,Down,0.776133701222435,0.946560686060595
675,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.7774280145067,0.94673455988816
676,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.779676710755961,0.947407247265651
677,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Down,0.780285530898839,0.947407247265651
678,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Down,0.781500631371357,0.947483066352884
679,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.785778038359649,0.949991314563882
680,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.785880892826569,0.949991314563882
681,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.7875077940011,0.950560068529962
682,WP_PROLACTIN_SIGNALING,69,Down,0.790099056044251,0.951421563755319
683,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Up,0.791374462055188,0.951421563755319
684,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,30,Down,0.791693855971579,0.951421563755319
685,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Up,0.800227504015357,0.951541765714757
686,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.802120602328033,0.951541765714757
687,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.80216932511936,0.951541765714757
688,WP_NEUROINFLAMMATION,10,Up,0.802940676360291,0.951541765714757
689,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.808531794895524,0.951541765714757
690,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.808631461545569,0.951541765714757
691,WP_TCELL_ACTIVATION_SARSCOV2,60,Up,0.808993772567732,0.951541765714757
692,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Up,0.809132965249729,0.951541765714757
693,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Down,0.810725695949069,0.951541765714757
694,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.811421705317856,0.951541765714757
695,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.812030950695009,0.951541765714757
696,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.812993928870745,0.951541765714757
697,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.812994489040281,0.951541765714757
698,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.816068893862534,0.951541765714757
699,WP_FRAGILE_X_SYNDROME,83,Down,0.816266995396351,0.951541765714757
700,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.81791851047953,0.951541765714757
701,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.818348522751149,0.951541765714757
702,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.819852175288239,0.951541765714757
703,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.820735215239016,0.951541765714757
704,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.821235708534646,0.951541765714757
705,WP_HEME_BIOSYNTHESIS,8,Up,0.821235708534646,0.951541765714757
706,WP_NUCLEOTIDE_GPCRS,5,Down,0.821300924129182,0.951541765714757
707,WP_PREIMPLANTATION_EMBRYO,21,Up,0.821578957244407,0.951541765714757
708,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.822027715287626,0.951541765714757
709,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Up,0.822133907355878,0.951541765714757
710,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.823642384213446,0.951541765714757
711,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.824364234763818,0.951541765714757
712,WP_ANGIOGENESIS,13,Down,0.824521506212102,0.951541765714757
713,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.82901419787778,0.951541765714757
714,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.830649054717926,0.951541765714757
715,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.833009690656331,0.951541765714757
716,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.833098103562598,0.951541765714757
717,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.833925014219244,0.951541765714757
718,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.833992927421943,0.951541765714757
719,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.834128441955125,0.951541765714757
720,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Down,0.834460019197371,0.951541765714757
721,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.83462483343107,0.951541765714757
722,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.836409342615514,0.952132544221044
723,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Down,0.838050463275166,0.952132544221044
724,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.839716219614407,0.952132544221044
725,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.83977627075457,0.952132544221044
726,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Up,0.842535969702303,0.95394568470426
727,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.844132603707363,0.954438789886454
728,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.846014571279087,0.954470064689741
729,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.849050222958731,0.954470064689741
730,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.849378853238258,0.954470064689741
731,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.849568303056678,0.954470064689741
732,WP_TRANSSULFURATION_PATHWAY,8,Down,0.849966043008383,0.954470064689741
733,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.85448064970279,0.95782439105631
734,WP_NEPHROGENESIS,4,Up,0.855642493434271,0.95782439105631
735,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,106,Down,0.857416068540688,0.95782439105631
736,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.857614053305893,0.95782439105631
737,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.85919088639054,0.958283458090941
738,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.862889364049745,0.960268281117525
739,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.86416098073107,0.960268281117525
740,WP_EFFECTS_OF_MFN2_MUTATION,18,Down,0.865270013858642,0.960268281117525
741,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.865643304511053,0.960268281117525
742,WP_SEROTONIN_AND_ANXIETY,7,Down,0.869316596856957,0.963043453660941
743,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.871381524583515,0.964031780898586
744,WP_P38_MAPK_SIGNALING,31,Down,0.879731513458541,0.967389729722121
745,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.879955878192297,0.967389729722121
746,WP_PLEURAL_MESOTHELIOMA,254,Down,0.880805809263231,0.967389729722121
747,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.881273140013082,0.967389729722121
748,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.881391613172376,0.967389729722121
749,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.882202469209336,0.967389729722121
750,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Down,0.882654862885147,0.967389729722121
751,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.884486486665596,0.968106380877656
752,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.887769114177548,0.968579293703215
753,WP_CELL_CYCLE,95,Down,0.888169925473766,0.968579293703215
754,WP_PRIMARY_OVARIAN_INSUFFICIENCY,88,Down,0.888453512715601,0.968579293703215
755,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.893196912217632,0.972460744162773
756,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.897421817879912,0.975768167059905
757,WP_BLADDER_CANCER,29,Down,0.898767816317645,0.97594074638455
758,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.905472627433098,0.977752365571895
759,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.906284521125773,0.977752365571895
760,WP_VALPROIC_ACID_PATHWAY,9,Up,0.906788510716004,0.977752365571895
761,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.908318110442349,0.977752365571895
762,WP_LUNG_PATHOLOGY_OF_COVID19,14,Down,0.908585418689313,0.977752365571895
763,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.910792003801028,0.977752365571895
764,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.910949072429635,0.977752365571895
765,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.91103502013614,0.977752365571895
766,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.912274184975514,0.977752365571895
767,WP_NAD_METABOLISM,12,Down,0.912330978581075,0.977752365571895
768,WP_OVARIAN_INFERTILITY,21,Up,0.915588272643496,0.978166595109759
769,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Up,0.915604241212515,0.978166595109759
770,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.916287443107682,0.978166595109759
771,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.918900655225856,0.97952058254097
772,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.91993903859079,0.97952058254097
773,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.921937868813913,0.98037894976072
774,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Up,0.92569108886463,0.98275397207803
775,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.927035373211592,0.98275397207803
776,WP_APOPTOSIS_MODULATION_AND_SIGNALING,77,Down,0.927758007703834,0.98275397207803
777,WP_GPR40_PATHWAY,8,Up,0.930732977750082,0.984394838009761
778,WP_IL17_SIGNALING,25,Up,0.932965848037444,0.984394838009761
779,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.933733609894636,0.984394838009761
780,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.934097291542109,0.984394838009761
781,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.937994204727264,0.987032334956808
782,WP_ENDOMETRIAL_CANCER,49,Up,0.939762886608368,0.987032334956808
783,WP_ALSTROM_SYNDROME,27,Down,0.940202333663237,0.987032334956808
784,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.94315681357446,0.988871046885467
785,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Up,0.951238267530127,0.993173468048802
786,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.95354448926925,0.993173468048802
787,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.95476391674998,0.993173468048802
788,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.959508537013439,0.993173468048802
789,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.959636308269666,0.993173468048802
790,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Down,0.962069393652817,0.993173468048802
791,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.963080929785796,0.993173468048802
792,WP_DNA_REPLICATION,36,Down,0.963253849906114,0.993173468048802
793,WP_IL18_SIGNALING,189,Up,0.963786953236078,0.993173468048802
794,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.965557669199626,0.993173468048802
795,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Up,0.969593576103794,0.993173468048802
796,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.971123106485757,0.993173468048802
797,WP_NRXN1_DELETION_SYNDROME,2,Up,0.971800832915597,0.993173468048802
798,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Up,0.972505725664875,0.993173468048802
799,WP_ENDODERM_DIFFERENTIATION,84,Up,0.973182710508756,0.993173468048802
800,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.973329602532624,0.993173468048802
801,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.97403959502596,0.993173468048802
802,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.977831859930179,0.993173468048802
803,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Up,0.978254602750466,0.993173468048802
804,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.979923337100046,0.993173468048802
805,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,61,Down,0.980810194839446,0.993173468048802
806,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.981031296200017,0.993173468048802
807,WP_HUNGER_AND_SATIETY,2,Down,0.981203729365743,0.993173468048802
808,WP_GPCRS_OTHER,12,Down,0.982041640453369,0.993173468048802
809,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.984161872918725,0.993173468048802
810,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,175,Up,0.98439202317285,0.993173468048802
811,WP_EGFEGFR_SIGNALING,138,Up,0.984575425646818,0.993173468048802
812,WP_IDO_METABOLIC_PATHWAY,8,Down,0.985468068720206,0.993173468048802
813,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.985819365647915,0.993173468048802
814,WP_G1_TO_S_CELL_CYCLE_CONTROL,52,Up,0.987453337263963,0.993173468048802
815,WP_MIRNA_BIOGENESIS,6,Down,0.987681614184563,0.993173468048802
816,WP_EICOSANOID_SYNTHESIS,13,Down,0.9881880244699,0.993173468048802
817,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.988287522608755,0.993173468048802
818,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Up,0.988340507133723,0.993173468048802
819,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.993275744720075,0.996576437297137
820,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.994873841040574,0.996576437297137
821,WP_B_CELL_RECEPTOR_SIGNALING,85,Up,0.995440866835747,0.996576437297137
822,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.996576437297137,0.996576437297137
